{
  "docId": "019dd923-5ca1-7489-b639-9565d55e55d2",
  "docSlug": "22be84535de3e132",
  "documentTitle": "ovid-19 Special Primer (2020)",
  "authorId": "OliverWyman",
  "authorName": "Oliver Wyman",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.4,
  "pageNumber": 56,
  "pageCount": 61,
  "prevPage": 55,
  "nextPage": 57,
  "slideType": "diagnosis",
  "function": "diagnose",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "photo"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b639-9565d55e55d2/56",
  "deckHref": "/decks/019dd923-5ca1-7489-b639-9565d55e55d2",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-9565d55e55d2.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-9565d55e55d2#slide-56",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "This means that any potential vaccine against SARS-CoV-2 would only grant short-term immunity, requiring repeated vaccinations over the course of a year",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-d9ef-7323-a2dd-f73f71d8191c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "image",
      "text": "SARS-CoV-2 virus and antibodies",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1bb627b7-726a-4d01-8d37-6317a25acb7e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.3,
        "x": 0.65,
        "y": 0.25
      },
      "kind": "list",
      "text": "A vaccine stimulates the immune system to produce antibodies against a disease. Antibodies are disease-specific proteins that tag germs or infected cells for attack. Efforts are complicated by news that antibodies are not long-lasting, implying short-term immunity.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a4bcc0e3-7cde-49ca-a4a4-2c3373502186",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Antibodies against SARS-CoV-2 recognize the virus and allow the immune system to destroy it before it can multiply to vast numbers",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9cf119c9-6672-43e6-90fc-c6f0ea7070a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.05,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Sources: CDC (link 1, link 2); New England Journal of Medicine (link); Scientific Animations (link); The Guardian (link); The New York Times (link).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4ba11b03-260c-4056-b988-c2f8ec8c7314",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "AN EFFECTIVE VACCINE AGAINST SARS-COV-2 WILL IDEALLY PRODUCE LASTING ANTIBODIES",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49da1a50-943e-456b-8fdd-10e52ddbedf0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.65,
        "y": 0.2
      },
      "kind": "title",
      "text": "Background",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6622ea9d-f029-49ff-adfc-12350d359f12",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 60,
      "from": 55,
      "beatId": "d7250bf2-af3c-4bb0-b2fc-515e0efa5cd6",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "The document provides evidence and data to support its claims and recommendations.",
      "position": 6,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 56,
      "from": 55,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "c143339e-a1fb-4606-9a30-89132e506710",
      "evidence": "The document highlights the importance of effective vaccine trials.",
      "position": 2,
      "objective": "Highlight the importance of effective vaccine trials",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.7,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}